Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Ann N Y Acad Sci ; 986: 570-8, 2003 Apr.
Article in English | MEDLINE | ID: mdl-12763891

ABSTRACT

The collecting duct is the site of final Na reabsorption according to Na balance requirements. Using isolated rat cortical collecting ducts (CCD) and mpkCCD(cl4) cells, a mouse cortical collecting duct cell line, we have studied the physiological control of Na,K-ATPase, the key enzyme that energizes Na reabsorption. Aldosterone, a major regulator of Na transport by the collecting duct, stimulates Na,K-ATPase activity through both recruitment of intracellular pumps and increased total amounts of Na pump subunits. This effect is observed after a lag time of 1 hour and is independent of Na entry through ENaC, but requires de novo transcription and translation. Vasopressin and cAMP, its second messenger, stimulate Na,K-ATPase activity within minutes through translocation of Na pumps from a brefeldin A-sensitive intracellular pool to the plasma membrane. Dysregulation of collecting duct Na,K-ATPase activity is at least in part responsible of the Na retention observed in nephritic syndrome. In this setting, Na,K-ATPase activity and subunit synthesis are specifically increased in CCD. In conclusion, aldosterone, vasopressin, and intracellular Na control the cell surface expression of Na,K-ATPase and translocation from intracellular stores is a major mechanism of regulation of Na,K-ATPase activity in collecting duct principal cells.


Subject(s)
Aldosterone/physiology , Kidney Tubules, Collecting/physiology , Sodium-Potassium-Exchanging ATPase/metabolism , Sodium/metabolism , Aldosterone/pharmacology , Animals , Cyclic AMP/physiology , Humans , Kidney Tubules, Collecting/enzymology , Mammals , Models, Biological , Nephrotic Syndrome/enzymology , Nephrotic Syndrome/physiopathology , Vasopressins/pharmacology
2.
Mol Cell Biol ; 22(3): 816-34, 2002 Feb.
Article in English | MEDLINE | ID: mdl-11784858

ABSTRACT

We previously showed that Hsp27 protects against apoptosis through its interaction with cytosolic cytochrome c. We have revisited this protective activity in murine cell lines expressing different levels of Hsp27. We report that Hsp27 also interferes, in a manner dependent on level of expression, with the release of cytochrome c from mitochondria. Moreover, a decreased level of endogenous Hsp27, which sensitized HeLa cells to apoptosis, reduced the delay required for cytochrome c release and procaspase 3 activation. The molecular mechanism regulating this function of Hsp27 is unknown. In our cell systems, Hsp27 is mainly cytosolic and only a small fraction of this protein colocalized with mitochondria. Moreover, we show that only a very small fraction of cytochrome c interacts with Hsp27, hence excluding a role of this interaction in the retention of cytochrome c in mitochondria. We also report that Bid intracellular relocalization was altered by changes in Hsp27 level of expression, suggesting that Hsp27 interferes with apoptotic signals upstream of mitochondria. We therefore investigated if the ability of Hsp27 to act as an expression-dependent modulator of F-actin microfilaments integrity was linked to the retention of cytochrome c in mitochondria. We show here that the F-actin depolymerizing agent cytochalasin D rapidly induced the release of cytochrome c from mitochondria and caspase activation. This phenomenon was delayed in cells pretreated with the F-actin stabilizer phalloidin and in cells expressing a high level of Hsp27. This suggests the existence of an apoptotic signaling pathway linking cytoskeleton damages to mitochondria. This pathway, which induces Bid intracellular redistribution, is negatively regulated by the ability of Hsp27 to protect F-actin network integrity. However, this upstream pathway is probably not the only one to be regulated by Hsp27 since, in staurosporine-treated cells, phalloidin only partially inhibited cytochrome c release and caspase activation. Moreover, in etoposide-treated cells, Hsp27 still delayed the release of cytochrome c from mitochondria and Bid intracellular redistribution in conditions where F-actin was not altered.


Subject(s)
Cytochrome c Group/metabolism , Heat-Shock Proteins , Neoplasm Proteins/metabolism , 3T3 Cells , Actins/metabolism , Animals , Apoptosis/physiology , BH3 Interacting Domain Death Agonist Protein , Carrier Proteins/metabolism , Caspase 3 , Caspases/metabolism , Cell Line , Enzyme Activation , Etoposide/pharmacology , Gene Expression , Glutathione/metabolism , HSP27 Heat-Shock Proteins , HeLa Cells , Humans , Kinetics , Mice , Mitochondria/metabolism , Models, Biological , Molecular Chaperones , Neoplasm Proteins/genetics , Staurosporine/pharmacology
3.
J Am Soc Nephrol ; 12(11): 2241-2252, 2001 Nov.
Article in English | MEDLINE | ID: mdl-11675400

ABSTRACT

Renal sodium retention is responsible for ascites and edema in nephrotic syndrome. In puromycin aminonucleoside (PAN)-induced nephrosis, sodium retention originates in part from the collecting duct, and it is associated with increased Na,K-ATPase activity in the cortical collecting duct (CCD). The aims of this study were to evaluate whether the outer medullary collecting duct (OMCD) also participates to sodium retention and to determine the mechanisms responsible for stimulation of Na,K-ATPase in CCD. PAN nephrosis increased Na,K-ATPase activity in the CCD but not in OMCD. The two-fold increase of Na,K-ATPase activity in CCD was associated with two-fold increases in the number of alpha and beta Na,K-ATPase subunits mRNA determined by quantitative RT-PCR and of the total amount of Na,K-ATPase alpha subunits estimated by Western blotting. PAN nephrosis also increased two-fold the amount of Na,K-ATPase alpha subunit at the basolateral membrane of CCD principal cells, as determined by Western blotting after biotinylation and streptavidin precipitation and by immunofluorescence. The intracellular pool of latent Na,K-ATPase units also increased in size and was no longer recruitable by vasopressin and cAMP. This unresponsiveness of the intracellular pool of Na,K-ATPase to vasopressin was not the result of any alteration of the molecular and functional expression of the vasopressin V(2) receptor/adenylyl cyclase (AC) complex. It is concluded that PAN nephrosis (1) does not alter sodium reabsorption in OMCD, (2) is associated with increased synthesis and membrane expression of Na,K-ATPase in the CCD, and (3) alters the normal trafficking of intracellular Na,K-ATPase units to the basolateral membrane.


Subject(s)
Arginine Vasopressin/pharmacology , Kidney Tubules, Collecting/drug effects , Kidney Tubules, Collecting/enzymology , Nephrosis/chemically induced , Nephrosis/enzymology , Puromycin Aminonucleoside , Renal Agents/pharmacology , Sodium-Potassium-Exchanging ATPase/metabolism , Absorption , Animals , Kidney Tubules, Collecting/metabolism , Kidney Tubules, Collecting/pathology , Male , Nephrosis/metabolism , Nephrosis/pathology , Rats , Rats, Sprague-Dawley , Sodium/metabolism , Subcellular Fractions/enzymology
SELECTION OF CITATIONS
SEARCH DETAIL
...